Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
LAGUNA HILLS, Calif., Sept. 06, 2016 -- Sonendo®, Inc. the developer of a breakthrough technology for the endodontic marketplace, announced today that Bjarne Bergheim, President and Chief Executive Officer, will be presenting at the Baird 2016 Global Health Conference in New York City on Wednesday, September 7, 2016 at 2:35 pm EDT.
About the event, Bjarne Bergheim stated, “Sonendo® is commercializing the GentleWave® Procedure as an alternative to standard Root Canal Treatment that improves patient outcomes and I look forward to sharing our story and milestones at this year’s conference.”
About Sonendo®
Sonendo, Inc. is a privately held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave System, available in the US, shows significant improvements in clinical efficacy, and treatment efficiency when compared to conventional root canal techniques1-2. For more information please visit: www.sonendo.com.
1Molina B et al. (2015) J Endod. 41:1701-05. 2Haapasalo M et al. (2014) J Endod. 40:1178-81.
Forward-Looking Statements
This announcement contains forward-looking statements based on management's beliefs, assumptions and expectations on information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
Media Contact: Bob Guyatt Vice President of Marketing 949.766.3636
